Tilray, Inc.https://pcaobus.org/form-ap-filings/26734/26734Tilray, Inc.267346/27/2018 10:53:49 AM2017b7a19526-de04-4da0-bc94-7123f0532f4c1208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)702307Tilray, Inc.1731348TLRY0120846690David Donald Dalziel0120846690True
Fennec Pharmaceuticals Inc.https://pcaobus.org/form-ap-filings/6296/6296Fennec Pharmaceuticals Inc.62964/18/2017 3:37:59 PM20163e150e7c-b890-431b-a4f5-144f768ca9a21208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)204003Fennec Pharmaceuticals Inc.1211583FENC; FRX.; ADRXF; FRX.WT0120846690David Donald Dalziel0120846690True
Brookfield Business Partners L.P.https://pcaobus.org/form-ap-filings/4707/4707Brookfield Business Partners L.P.47073/31/2017 7:22:27 AM20169f4e91ce-f6e3-4d20-b48c-af15133067bb1208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)630466Brookfield Business Partners L.P.1654795BBU; BBU.UN0120846690David Donald Dalziel0120846690True